How high is the incidence and mortality rate of melanoma now?

It is generally very high, and if you don't go through ** after getting this disease, it is generally 100% mortal, and if you do it, then the possibility of ** is also very small.

Morbidity and mortality are sometimes as high as 90%, so it's really a cancer. It should be done immediately** and some relevant medications should be consumed.

At present, the incidence of melanoma is generally 1 in 100,000, and the mortality rate is generally 30%, which is still relatively high.

It is very high, as long as you suffer from melanoma, the general incidence rate is more than 95%, and the mortality rate is very high.

The morbidity and mortality of melanoma are not very high, and they are very low in the country because they can be surgically removed at an early stage.

The mortality rate is not very high. But if you get a very good ** and a very good maintenance, then the morbidity becomes very low, and the mortality rate becomes very low.

Compared with cancer, the morbidity and mortality rate are not so high, and this disease must be treated in time, so that it can be better accepted**.

The incidence of this disease is not high, but the mortality rate is very high, so once you find this disease, you must go to the hospital as soon as possible**.

The incidence is very high, so you must pay attention to your physical condition at ordinary times, and you must regulate your body, and you should seek medical attention in time when you encounter problems.

Melanoma is the highest number of cancer deaths, in addition to the high probability of genetic mutations in melanocytes themselves, the high degree of malignancy and strong metastatic ability, resulting in difficulties, but also because Taiwanese patients are not aware of the disease too late to seek medical treatment, when melanoma enters the advanced stage, the options are very limited.

Zhang Wenzhen, director of the Department of Oncology of Linkou Chang Gung Hospital, said that the 2018 Nobel Prize in Biomedical Medicine, one of the immune checkpoint inhibitors of cancer immunity, anti-PD-1 monoclonal antibody, ignites a ray of life for advanced patients, and is a very important way to assist and inoperable patients after melanoma.

The biggest bottleneck is the first diagnosis, that is, the late stage, and the ** rate is more than 6%.

Melanoma is a cancer that develops from melanocytes, and the lesions can grow in **anywhere, more often on the soles of the feet, toes or under the nails, resulting in a delay in thinking that it is a general mole or birthmark without paying attention. Liao Yihua, the attending physician of the ** Department of National Taiwan University Hospital, suggested that if there is a mole on the body, it can be observed from five parts whether it is necessary to see a doctor as soon as possible Asymmetry, uneven edges, uneven color, diameter greater than centimeters, and appearance becomes larger or changes. Dr. Liao Yihua said that nearly 40% of patients in Taiwan are in the third and fourth stages of their first diagnosis, and most of them are elderly people with low awareness of the disease.

Even after surgery**, the rate of advanced ** is still as high as more than 6%, and an average of 1 in 2 patients may **.

9% of patients do not need to wait for the immune checkpoint inhibitor Qingjube to help reduce the ** rate.

Director Zhang Wenzhen pointed out that about 16% of patients with BRAF gene can choose targeted drugs to give it a go, but the remaining 84% of patients without BRAF gene can only choose interleukin and interferon-based**. As for the immune checkpoint inhibitor anti-PD-1 monoclonal antibody, there is no need to consider the BRAF gene, which has become a new dawn for these patients.

Physicians call for early use of anti-PD-1 drugs to help two major goals.

Director Zhang Wenzhen suggested that the sooner you start using it, the better for the patient, avoiding it and prolonging the survival period is the most important goal of melanoma, so that the patient can accept the postoperative treatment without affecting the quality of life.

Dr. Liao Yihua also appealed that there are now immune checkpoint inhibitors anti-PD-1 that can be provided to patients as a new choice, and in the face of the most difficult cancer, do not give up easily.

The incidence is very high, because people nowadays are very inattentive to their physical health, which will allow harmful substances to affect the body, which will eventually lead to the onset of the disease.

This seems to be a malignant tumor, so the incidence is particularly high, and in such a situation, I think you should cooperate with the doctor** and actively carry out chemotherapy.

The incidence is still relatively high, and it will also be reversed, and there will be enlargement in the part, and it can only be removed by surgery under normal circumstances.

Compared with foreign countries, it is not high, about 1 in 100,000, but due to the lack of awareness of the severity of the disease by doctors and patients, it is often too late when the doctor is treated, and the effect is extremely unsatisfactory.

The incidence of melanoma disease in China is not very high, and the incidence rate in Caucasians is very high, but in recent years, the number of people with melanoma is rising, and the choice of melanoma method is very important.

Melanoma is a common tumor caused by the excessive proliferation of abnormal melanocytes, with a very high degree of malignancy, accounting for a large proportion of tumor deaths. It occurs mostly in or near ** mucosa, but also in the leptomeninges and choroids. The incidence varies with race, geography and ethnicity, with the incidence being much higher in whites than in blacks, and up to 17.1 million in whites living in Queensland, Australia.

Although China is a low-incidence area of melanoma, the incidence rate has been increasing in recent years.

Each year, there are 25,000 new cases of malignant melanoma in the United States, and about 6,000 people die. The incidence is increasing rapidly. Sun exposure is a risk factor, as are family history, development of malignant nevus, large congenital melanocytic nevus, and dysplastic nevus syndrome.

Blacks are rare.

Don't listen to their nonsense and mislead people.

Although melanoma is a type of tumor, accounting for the third largest malignant tumor, the benign one is called "nevus" or "colored nevus", and the malignant one is called "malignant melanoma". There are significant racial differences in the incidence of malignant melanoma, with a higher incidence in whites, a lower incidence in yellows, and very few in blacks, and the deeper the pigmentation, the lower the incidence. The incidence of sun-exposed sites in yellow people is very low.

In fact, the chance of a nevus getting worse is extremely low. The incidence of melanoma in China is only 1 in 100,000. Generally, black moles that grow on the face, in the hair, or have a smooth surface are not too much of a problem.

Exercise is the best way to fight cancer. So, if you're really scared, do more exercise, it's good for your body.

Not necessarily, malignant melanoma is malignant.

No, it is divided into benign and malignant!